Vimarsana
Biggest News Aggregation in the World

Page 37 - Euronext News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Euronext. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Euronext Today - Breaking & Trending Today

NANOBIOTIX Announces US FDA Protocol Acceptance for New Randomized Phase 2 Study Evaluating ... - Vimarsana News

NANOBIOTIX Announces US FDA Protocol Acceptance for New Randomized Phase 2 Study Evaluating ...

PARIS and CAMBRIDGE, Mass., May 14, 2024 (GLOBE NEWSWIRE) -- NANOBIOTIX (Euronext: NANO –– NASDAQ: NBTX – the ‘‘Company’’), a late-clinical stage biotechnology company pioneering nanoparticle-based therapeutic approaches to expand

argenx to Present at BofA Securities 2024 Health Care Conference - argenx (NASDAQ:ARGX) - Vimarsana News

argenx to Present at BofA Securities 2024 Health Care Conference - argenx (NASDAQ:ARGX)

May 7, 2024Amsterdam, the Netherlands – argenx ((Euronext &amp, NASDAQ:ARGX), a global immunology company committed to improving the lives of people suffering from severe autoimmune diseases, today announced that

Race for Europe's first 'real-time' stock trade tape heats up | WSAU News/Talk 550 AM · 99.9 FM - Vimarsana News

Race for Europe's first 'real-time' stock trade tape heats up | WSAU News/Talk 550 AM · 99.9 FM

By Huw Jones LONDON (Reuters) - Banks and asset managers are vying with Europe’s exchanges to develop technology that can deepen the pool of investors in the continent’s capital markets and better compete with Wall Street. The United States has lon...

Source: wsau.com
Innate Pharma Announces Conference Call and Webcast for Q1 2024 Business Update - Vimarsana News

Innate Pharma Announces Conference Call and Webcast for Q1 2024 Business Update

07.05.2024 - Regulatory News: Innate Pharma SA (Euronext Paris: IPH; Nasdaq: IPHA) (“Innate” or the “Company”), today announced that the Company will hold a conference call on Tuesday, May 14, 2024, at 2 p.m. CEST / 8 a.m. EDT, to give an update on business ...

GenSight Biologics Announces a Successful Offering for an Amount Over €9.2 Million - Vimarsana News

GenSight Biologics Announces a Successful Offering for an Amount Over €9.2 Million

GenSight Biologics shares resume trading today Over €9.2 million offering of ABSA composed of a reserved offering aimed at specialized investors and a private placement More than 50% of the...